Bin Sabbar NS, Alowirdi FS, Basakran FA, Al-Badr LA, Assiri RA, Alshahrani WA, Althubaiti A, Damlaj M. Addition of rituximab to hyper-CVAD improves overall survival in newly diagnosed Burkitt leukemia/lymphoma from the Middle East and North Africa region. Int J Community Med Public Health [Internet]. 2019 Sep. 26 [cited 2026 Mar. 30];6(10):4199-203. Available from: https://www.ijcmph.com/index.php/ijcmph/article/view/5294